The third most cited article was published by Ference et al.14The objective of this study was to investigate whether the natural random allocation mediated by polymorphisms of the NPC1L1 gene, HMGCR gene, or both (targets of combined therapy) could reduce LDL‐C levels and subsequently lower the risk of CHD.14 This evidence concerns the gene HMGCR and coronary artery disorder.